Pfizer: all 4,072 studies
Page 23 of 41. Open to participants first (153), then studies with results posted, then the rest; newest registration first within each.
- A Study to Understand How the Study Medicine Called ARV-471 is Processed in Healthy AdultsCompletedNCT05930925Phase 1
- A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced MelanomaTerminatedNCT05926960Phase 2
- A Study for Multiple Tablet Forms of The Study Medicine (PF-07220060) in Healthy AdultsCompletedNCT05923411Phase 1
- A Study to Learn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal-bow-sai-klib)CompletedNCT05912933
- Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2Active, not recruitingNCT05911295Phase 3
- Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast CancerActive, not recruitingNCT05909397Phase 3
- Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.WithdrawnNCT05905341Phase 1
- HER2 and LA/mUC: A Multi-country Chart Review Cohort StudyCompletedNCT05902494
- A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in ChinaCompletedNCT05896774Phase 1
- A Study to Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B Cell Lymphoma.TerminatedNCT05896163Phase 1/2
- A Study to Learn About the Adherence and Clinical Outcomes in Colombian Patients With an E-Device for Etanercept Administration in Rheumatoid ArthritisTerminatedNCT05891600
- A Study to Learn About How Loss of Liver Function Affects the Blood Levels of the Study Medicine Called PF-07817883.CompletedNCT05884554Phase 1
- Study of GBT021601 in Participants With Renal ImpairmentTerminatedNCT05878704Phase 1
- Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims DataTerminatedNCT05876377
- A Study to Learn About Effect of Sisunatovir in Healthy Adult Male ParticipantsCompletedNCT05873764Phase 1
- A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).CompletedNCT05858749
- A Study to Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance the Effects of the Vaccine Which is Given to AdultsCompletedNCT05831124Phase 1
- Atrial Fibrillation Data Linkage Non-Interventional StudyCompletedNCT05810727
- A Study to Learn How Different Amounts of the Study Medicine Called PF-07328948 Are Tolerated and Act in the Body in Healthy AdultsCompletedNCT05807490Phase 1
- To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy AdultsActive, not recruitingNCT05805826Phase 1/2
- A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma (TCR-MM) Are Treated in Italian Centers for Blood Related DiseasesCompletedNCT05742217
- A Study to Learn About the Study Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Advanced Breast Cancer in ChinaCompletedNCT05732428Phase 1
- A Study to Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal Bow Sai Klib)CompletedNCT05709158
- A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy AdultsTerminatedNCT05703607Phase 1/2
- A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder CancerTerminatedNCT05699135
- A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple MyelomaActive, not recruitingNCT05675449Phase 1
- Ngenla Subcutaneous Injection Special InvestigationActive, not recruitingNCT05602766
- A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) TranquilloCompletedNCT05583526Phase 3
- TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)TerminatedNCT05573555Phase 1/2
- A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid TumorsTerminatedNCT05571839Phase 1
- A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial CancerTerminatedNCT05568407
- A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic MalignanciesCompletedNCT05567887Phase 1
- A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative ColitisTerminatedNCT05549323Phase 1
- TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)Active, not recruitingNCT05548127Phase 1/2
- a Non-interventional Study of Sildenafil in the Treatment of Pulmonary Arterial Hypertension (PAH) in Adults From ChinaCompletedNCT05546125
- A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19WithdrawnNCT05545319Phase 2
- A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsActive, not recruitingNCT05538130Phase 1
- A Study to Describe the Safety and Immunogenicity of 20vPnC in Infants in India and TaiwanCompletedNCT05512819Phase 3
- Korean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients With Growth Disturbance Due to Insufficient Secretion of Growth HormoneActive, not recruitingNCT05509894
- Outcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBCCompletedNCT05505175
- A Preliminary Study to Evaluate PF-07264660 in Healthy ParticipantsCompletedNCT05496738Phase 1
- A Study to Describe Treatment Patterns of Advanced Breast Cancer in Poland in the Real-world Data SettingCompletedNCT05478590
- An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15)CompletedNCT05477524Phase 3
- Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple MyelomaNo longer availableNCT05462639
- A First-In-Human Study of the Study Medicine, Called PF-07291177, in Healthy Adult ParticipantsWithdrawnNCT05434091Phase 1
- Study of Fordadistrogene Movaparvovec in Early Stage Duchenne Muscular DystrophyTerminatedNCT05429372Phase 2
- A Study to Learn How the Study Medicine Called PF-07275315 Works in Healthy PeopleCompletedNCT05411588Phase 1
- Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in JapanCompletedNCT05399329
- An Observational Chart Review Study To Describe The Real-World Outcomes And Use Of Avelumab In Combination With Axitinib For Treatment Of Patients With aRCC In The UKCompletedNCT05394493
- A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.Active, not recruitingNCT05387980
- A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19TerminatedNCT05386472Phase 1
- Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002)Active, not recruitingNCT05382364Phase 1
- Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in ScotlandCompletedNCT05363488
- A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.Active, not recruitingNCT05355701Phase 1
- A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell DiseaseTerminatedNCT05348915Phase 3
- Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After TransplantActive, not recruitingNCT05317416Phase 3
- A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.Active, not recruitingNCT05295290Phase 4
- Bioavailability Study of Naloxone 5 Milligrams (mg) Intramuscular (IM) AutoinjectorCompletedNCT05264493Phase 1
- A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid TumorsActive, not recruitingNCT05262400Phase 1/2
- PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)WithdrawnNCT05259397Phase 1
- A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal CancerActive, not recruitingNCT05253651Phase 3
- A Safety Study of Brentuximab Vedotin in Participants With HIVWithdrawnNCT05244473Phase 1
- Pre-approval Single-patient Expanded Access for Elranatamab (PF-06863135)No longer availableNCT05238311
- PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid TumorsTerminatedNCT05233436Phase 1
- A Study of SGN-ALPV in Advanced Solid TumorsTerminatedNCT05229900Phase 1
- Voxelotor Brain Oxygenation and Neurocognitive StudyWithdrawnNCT05228821Phase 4
- A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of InfluenzaCompletedNCT05227001Phase 1
- Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) StudiesActive, not recruitingNCT05226871Phase 2
- A Study to Learn About the Study Medicine (Called Lorlatinib) in People With Liver DysfunctionCompletedNCT05224609Phase 1
- A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal CancerActive, not recruitingNCT05217446Phase 2
- Study of Pregnancy Outcomes in Women Exposed to Rimegepant During PregnancyActive, not recruitingNCT05198245
- A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid TumorsTerminatedNCT05194072Phase 1
- Study to Investigate the Mass Balance, Metabolism, and Excretion of [14C]PF-07321332 in Healthy Male Participants.WithdrawnNCT05178654Phase 1
- Crizotinib Continuation Clinical StudyActive, not recruitingNCT05160922Phase 4
- A Study to Look at the Health Outcomes of Patients With COVID-19 and InfluenzaActive, not recruitingNCT05160636
- Lorlatinib Continuation StudyActive, not recruitingNCT05144997Phase 4
- Analysis of the Real-world Prescription Pattern of Palbociclib Combination Therapy With Aromatase Inhibitor as a First Line Therapy in Metastatic Breast Cancer Patients Using the National Health Insurance Claims Data in South KoreaCompletedNCT05132101
- Korean Regulatory Post Marketing Surveillance for SomavertCompletedNCT05131100
- Assessment of the Effectiveness and Safety Outcome in Patients With Atrial Fibrillation Treated by Apixaban in BelgiumWithdrawnNCT05116267
- Safety and Efficacy Study of PF-06835375 in Primary Immune ThrombocytopeniaTerminatedNCT05070845Phase 2
- Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Recifercept in Healthy Chinese ParticipantsWithdrawnNCT05061277Phase 1
- Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are ClosingActive, not recruitingNCT05059522Phase 3
- European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal TherapiesCompletedNCT05043506
- High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in FranceCompletedNCT05038228
- A Study to Evaluate GBT021601 in Single and Multiple Doses in Healthy ParticipantsCompletedNCT05036512Phase 1
- Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults.Active, not recruitingNCT05035212Phase 3
- Korea Comirnaty Post-marketing SurveillanceActive, not recruitingNCT05032976
- Korea Post Marketing Surveillance (PMS) Study of Talzenna®WithdrawnNCT04982848
- Retrospective Real World Oxbryta® Data Collection and Analysis StudyCompletedNCT04930328
- Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf RegionCompletedNCT04916509
- A Study Comparing Subcutaneous Injection of Sayana Press In the Upper Arm Versus Anterior Thigh and AbdomenCompletedNCT04893798Phase 1
- A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various CancerWithdrawnNCT04889495
- Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.CompletedNCT04881045Phase 1
- Korean Post-marketing Surveillance for Xeljanz XRCompletedNCT04876781
- Bioequivalence Study for Crizotinib Encapsulated Microsphere Formulation (eMS)CompletedNCT04856293Phase 1
- Pfizer-BioNTech COVID-19 Vaccine Effectiveness Study - Kaiser Permanente Southern CaliforniaCompletedNCT04848584
- A Study of Marstacimab to Compare Prefilled Pen (PFP) Device to Prefilled Syringe (PFS) DeviceTerminatedNCT04832139Phase 1
- Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCActive, not recruitingNCT04821622Phase 3
- Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 YearsTerminatedNCT04821310Phase 2
- NOAC Portuguese Real World StudyWithdrawnNCT04808934